Home
Parmax Pharma Ltd PE Ratio

Parmax Pharma Ltd
NSE: PARMAXPHARMA
PE
Key Highlights
- The P/E Ratio of Parmax Pharma Ltd is 0 as of 22 Feb 15:30 PM .
- The P/E Ratio of Parmax Pharma Ltd changed from 21 on March 2021 to 0 on March 2024 . This represents a CAGR of -100.00% over 4 years.
- The Latest Trading Price of Parmax Pharma Ltd is ₹ 42.93 as of 21 Feb 15:30 .
- The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
- The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.
Historical P/E Ratio of Parmax Pharma Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Parmax Pharma Ltd
Company Fundamentals for Parmax Pharma Ltd

Parmax Pharma Ltd
NSE: PARMAXPHARMA
Share Price
Market Price of Parmax Pharma Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 42.93 |
20 Feb 2025 | 43.83 |
19 Feb 2025 | 39.95 |
18 Feb 2025 | 41.8 |
17 Feb 2025 | 38.03 |
14 Feb 2025 | 41.07 |
13 Feb 2025 | 41 |
12 Feb 2025 | 40.5 |
11 Feb 2025 | 45 |
10 Feb 2025 | 47.99 |
BlinkX Score for Parmax Pharma Ltd
Asset Value vs Market Value of Parmax Pharma Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/E Ratio
Company | Market Cap | PE Ratio |
---|
Parmax Pharma Ltd | 16.06 | - |
Sun Pharmaceuticals Industries Ltd | 394223 | 33.4 |
Divis Laboratories Ltd | 152610 | 73.8 |
Cipla Ltd | 119067 | 23.9 |
Torrent Pharmaceuticals Ltd | 102739 | 55.2 |
Dr Reddys Laboratories Ltd | 96124 | 17.9 |
Company | |
---|---|
Parmax Pharma Ltd | 16.06 |
Sun Pharmaceuticals Industries Ltd | 394223 |
Divis Laboratories Ltd | 152610 |
Cipla Ltd | 119067 |
Torrent Pharmaceuticals Ltd | 102739 |
Dr Reddys Laboratories Ltd | 96124 |
PE Ratio of Parmax Pharma Ltd Explained
₹16.06
Market cap
₹-2
Earnings
0.0X
PE Ratio
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.
P/E Ratio Formula
P/E ratio = (CMP of share/ Earning per share)
Types of Price to Earning Ratio
1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
PE Ratio of Pharmaceuticals Industry over time
PE Ratio of Top Sectors
Historical Market Cap of Parmax Pharma Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Parmax Pharma Ltd
Historical Revenue, EBITDA and Net Profit of Parmax Pharma Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Parmax Pharma Ltd
Revenue
EBITDA
Net Profit
Historical Dividend Payout of Parmax Pharma Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payout of Parmax Pharma Ltd
About Parmax Pharma Ltd
- Incorporated in Nov.'94, Parmax Pharma Ltd (PPL) was promoted by Jayantilal S Dhol, Purushottam J Bhalodi and Prabhudas D Hansalpara.
- The Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations ( CMO) business are the key pillar of Parmax's pharmaceutical operations. The Promoters were earlier into manufacturing of bulk drugs like Ampicilin, Amoxycillin, Cephalexin, Nalidixic Acid etc.
- The Company then discontinued their business activities for few years due to various reasons.
- Starting from their journey as a bulk drug manufacturer and speciality chemicals in 1994; the Company had set up a plant to manufacture and market bulk drugs like amoxycillin tri-hydrate, ampicillin tri-hydrate, cephalexin mono hydrate and nalidixic acid, at Hadamtala, Gujarat, with an installed capacity of 96 TPA.
Parmax Pharma Ltd News Hub
Parmax Pharma reports standalone net profit of Rs 0.01 crore in the June 2024 quarter
Net profit of Parmax Pharma reported to Rs 0.01 crore in the quarter ended June 2024 as against net
Read more
16 Aug 24
Parmax Pharma to declare Quarterly Result
Parmax Pharma will hold a meeting of the Board of Directors of the Company on 14 August 2024. Powere
Read more
09 Aug 24
Parmax Pharma to conduct AGM
Parmax Pharma announced that the Annual General Meeting (AGM) of the company will be held on 30 Sept
Read more
18 Sept 24
Parmax Pharma to discuss results
Parmax Pharma will hold a meeting of the Board of Directors of the Company on 14 November 2024 Power
Read more
07 Nov 24